全文获取类型
收费全文 | 3030篇 |
免费 | 182篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 121篇 |
妇产科学 | 75篇 |
基础医学 | 402篇 |
口腔科学 | 28篇 |
临床医学 | 407篇 |
内科学 | 473篇 |
皮肤病学 | 52篇 |
神经病学 | 265篇 |
特种医学 | 49篇 |
外科学 | 322篇 |
综合类 | 31篇 |
一般理论 | 3篇 |
预防医学 | 477篇 |
眼科学 | 37篇 |
药学 | 173篇 |
中国医学 | 3篇 |
肿瘤学 | 278篇 |
出版年
2024年 | 3篇 |
2023年 | 27篇 |
2022年 | 31篇 |
2021年 | 96篇 |
2020年 | 51篇 |
2019年 | 84篇 |
2018年 | 91篇 |
2017年 | 59篇 |
2016年 | 78篇 |
2015年 | 73篇 |
2014年 | 106篇 |
2013年 | 165篇 |
2012年 | 248篇 |
2011年 | 295篇 |
2010年 | 125篇 |
2009年 | 121篇 |
2008年 | 226篇 |
2007年 | 243篇 |
2006年 | 230篇 |
2005年 | 185篇 |
2004年 | 196篇 |
2003年 | 153篇 |
2002年 | 131篇 |
2001年 | 13篇 |
2000年 | 8篇 |
1999年 | 12篇 |
1998年 | 20篇 |
1997年 | 19篇 |
1996年 | 16篇 |
1995年 | 22篇 |
1994年 | 11篇 |
1993年 | 14篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 14篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1961年 | 1篇 |
排序方式: 共有3222条查询结果,搜索用时 15 毫秒
81.
We report a case of spontaneous familial pneumothorax in fraternal twin boys. The twins' family history is remarkable for reactive airway disease and a female sibling also born with spontaneous pneumothorax. The family had no history of connective tissue disorders, renal cancer, or dermatologic diseases. Analysis of the twins' α(1)-antitrypsin (AAT) genotype, phenotype, and serum concentration revealed that both were compound heterozygous for rare SERPINA1 alleles. These findings suggest a role for AAT deficiency in spontaneous pneumothorax of the newborn. To our knowledge, these are the first genetic data to support etiology of neonatal spontaneous familial pneumothorax. 相似文献
82.
83.
84.
Fang J Rhyasen G Bolanos L Rasch C Varney M Wunderlich M Goyama S Jansen G Cloos J Rigolino C Cortelezzi A Mulloy JC Oliva EN Cuzzola M Starczynowski DT 《Blood》2012,120(4):858-867
Bortezomib (Velcade) is used widely for the treatment of various human cancers; however, its mechanisms of action are not fully understood, particularly in myeloid malignancies. Bortezomib is a selective and reversible inhibitor of the proteasome. Paradoxically, we find that bortezomib induces proteasome-independent degradation of the TRAF6 protein, but not mRNA, in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) cell lines and primary cells. The reduction in TRAF6 protein coincides with bortezomib-induced autophagy, and subsequently with apoptosis in MDS/AML cells. RNAi-mediated knockdown of TRAF6 sensitized bortezomib-sensitive and -resistant cell lines, underscoring the importance of TRAF6 in bortezomib-induced cytotoxicity. Bortezomib-resistant cells expressing an shRNA targeting TRAF6 were resensitized to the cytotoxic effects of bortezomib due to down-regulation of the proteasomal subunit α-1 (PSMA1). To determine the molecular consequences of loss of TRAF6 in MDS/AML cells, in the present study, we applied gene-expression profiling and identified an apoptosis gene signature. Knockdown of TRAF6 in MDS/AML cell lines or patient samples resulted in rapid apoptosis and impaired malignant hematopoietic stem/progenitor function. In summary, we describe herein novel mechanisms by which TRAF6 is regulated through bortezomib/autophagy-mediated degradation and by which it alters MDS/AML sensitivity to bortezomib by controlling PSMA1 expression. 相似文献
85.
86.
87.
88.
Min-Hoe Chew Poh-Koon Koh Melinda Tan Kiat-Hon Lim Loi Carol Choong-Leong Tang 《World journal of surgery》2013,37(10):2468-2475
Background
The incidence of mismatch repair deficiency in colorectal cancer (CRC) in young people remains unknown in Asians. The present study assessed the clinicopathological features and efficacy of immunohistochemistry screening for Lynch syndrome in young Asian CRC patients.Material and methods
This was a retrospective review conducted in Singapore General Hospital between January 2006 and December 2010 of 240 unrelated patients under the age of 50. All patients had immunohistochemical (IHC) staining for mismatch repair proteins in resected CRC specimen data retrieved from a prospective computerized database.Results
A total of 21 % (n = 51) of the patients had abnormal IHC staining. Loss of staining for MLH1, MSH2, MSH6, and PMS2 proteins was observed in 10, 4, 6, and 13 % of tumors, respectively. Of the 22 patients who had abnormal staining of MLH1, 13 had concomitant abnormal staining for PMS2. One tumor specimen had abnormal staining in all four proteins. If the Amsterdam criteria alone were to be used, 86 % (n = 44) of the cohort would have not been detected for mismatch repair gene defects.Conclusions
The overall burden of germline mismatch repair deficiency in the Singapore population may be as high as 21 %. The Amsterdam criteria alone are inadequate to detect Lynch syndrome patients. The use of IHC staining of at least four mismatch repair proteins is a useful screening strategy for Lynch syndrome diagnosis. Routine screening of mismatch repair deficiency may be recommended for all young Asian CRC patients. 相似文献89.